BOSTON HEART FOUNDATION INC has a total of 16 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are MAXIMUS DIAGNOSTIC TECH LLC, EXPERIMENTAL RES CENTER CHINA ACADEMY OF CHINESE MEDICAL SCIENCES and OP T LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lees Ann M | 15 |
#2 | Law Simon W | 15 |
#3 | Lees Robert S | 15 |
#4 | Arjona Anibal A | 15 |
Publication | Filing date | Title |
---|---|---|
AU8364101A | Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis | |
US6632923B1 | Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis | |
US6605588B1 | Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis | |
CA2272243A1 | Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |